Halpin DMG - Search Results

1

Han MK, Agusti A, Celli BR, Criner GJ, Halpin DMG, Roche N, Papi A, Stockley RA, Wedzicha J, Vogelmeier CF. Han MK, et al. Among authors: halpin dmg. Am J Respir Crit Care Med. 2021 Feb 15;203(4):414-423. doi: 10.1164/rccm.202008-3328PP. Am J Respir Crit Care Med. 2021. PMID: 33211970 Free PMC article. No abstract available.

2

Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).

Celli B, Halpin D, Hepburn R, Byrne N, Keating ET, Goldman M. Celli B, et al. Respir Med. 2003 Jan;97 Suppl A:S35-43. Respir Med. 2003. PMID: 12564609 Free article. Clinical Trial.

3

Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data.

Halpin DM, Peterson S, Larsson TP, Calverley PM. Halpin DM, et al. Respir Med. 2008 Nov;102(11):1615-24. doi: 10.1016/j.rmed.2008.05.007. Epub 2008 Aug 8. Respir Med. 2008. PMID: 18691861 Free article.

4

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. Tashkin DP, et al. N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5. N Engl J Med. 2008. PMID: 18836213 Free article. Clinical Trial.

5

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators. Decramer M, et al. Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27. Lancet. 2009. PMID: 19716598 Clinical Trial.

6

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators. Troosters T, et al. Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25. Eur Respir J. 2010. PMID: 20185426 Free article. Clinical Trial.

7

Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial.

Halpin DM, Decramer M, Celli B, Kesten S, Leimer I, Tashkin DP. Halpin DM, et al. Lung. 2011 Aug;189(4):261-8. doi: 10.1007/s00408-011-9301-8. Epub 2011 Jun 16. Lung. 2011. PMID: 21678045 Free PMC article.

8

Comparison of the variability of the annual rates of change in FEV₁ determined from serial measurements of the pre- versus post-bronchodilator FEV₁ over 5 years in mild to moderate COPD: results of the lung health study.

Tashkin DP, Wang HJ, Halpin D, Kleerup EC, Connett J, Li N, Elashoff R. Tashkin DP, et al. Respir Res. 2012 Aug 15;13(1):70. doi: 10.1186/1465-9921-13-70. Respir Res. 2012. PMID: 22894725 Free PMC article. Clinical Trial.

9

Exacerbation frequency and course of COPD.

Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP. Halpin DM, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:653-61. doi: 10.2147/COPD.S34186. Epub 2012 Sep 21. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 23055714 Free PMC article.

10

Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.

Tashkin DP, Li N, Halpin D, Kleerup E, Decramer M, Celli B, Elashoff R. Tashkin DP, et al. Respir Med. 2013 Dec;107(12):1904-11. doi: 10.1016/j.rmed.2013.08.001. Epub 2013 Aug 22. Respir Med. 2013. PMID: 23972968 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page